Document Status

This document has been corrected

Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

10.1007/s10620-017-4598-7

Published Online: 2017-06-06

Journal: Digestive Diseases and Sciences•Publisher: Springer Science and Business Media LLC

Authors: A. Lembo•B. D. Cash•M. Pimentel•P. Schoenfeld•R. A. Wolf•R. J. Israel

This document has been corrected

Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

10.1007/s10620-017-4598-7

Published Online: 2017-06-06

Journal: Digestive Diseases and Sciences

Authors: A. Lembo•B. D. Cash•M. Pimentel•P. Schoenfeld•R. A. Wolf•R. J. Israel

NOW

2017-09-07•Erratum

Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

10.1007/s10620-017-4729-1

* information provided by CrossRef

2017-09-07•Erratum

10.1007/s10620-017-4729-1

* information provided by CrossRef

2017-06-06•Published